PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.14%
Revenue growth above 1.5x CVE's 12.50%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
34.16%
Gross profit growth similar to CVE's 32.69%. Walter Schloss would assume both firms track common industry trends.
163.86%
EBIT growth below 50% of CVE's 595.27%. Michael Burry would suspect deeper competitive or cost structure issues.
163.86%
Operating income growth under 50% of CVE's 595.27%. Michael Burry would be concerned about deeper cost or sales issues.
125.64%
Net income growth under 50% of CVE's 1293.62%. Michael Burry would suspect the firm is falling well behind a key competitor.
126.42%
EPS growth under 50% of CVE's 1350.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
124.53%
Diluted EPS growth under 50% of CVE's 1333.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.13%
OCF growth above 1.5x CVE's 21.87%. David Dodd would confirm a clear edge in underlying cash generation.
75.96%
FCF growth under 50% of CVE's 396.94%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
40.92%
Similar 10Y revenue/share CAGR to CVE's 41.70%. Walter Schloss might see both firms benefiting from the same long-term demand.
-41.24%
Negative 5Y CAGR while CVE stands at 41.70%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-72.36%
Negative 3Y CAGR while CVE stands at 41.70%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
164.63%
Positive long-term OCF/share growth while CVE is negative. John Neff would see a structural advantage in sustained cash generation.
-53.36%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-50.87%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-26.73%
Negative 10Y net income/share CAGR while CVE is at 307.69%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-90.82%
Negative 5Y net income/share CAGR while CVE is 307.69%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-85.31%
Negative 3Y CAGR while CVE is 307.69%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
148.96%
Equity/share CAGR of 148.96% while CVE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
5.84%
Equity/share CAGR of 5.84% while CVE is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-16.84%
Negative 3Y equity/share growth while CVE is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
397.82%
Dividend/share CAGR of 397.82% while CVE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
101.84%
Dividend/share CAGR of 101.84% while CVE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-50.10%
Negative near-term dividend growth while CVE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.32%
Our AR growth while CVE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
1.81%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.44%
Under 50% of CVE's 6.08%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
5.89%
We have some new debt while CVE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-50.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.